7WD-26725-12376
1 vaccination
2 coded responses
5 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 940 / CA
- Registered
- 2021-05-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-19
Dose 1 — Pfizer-BioNTech
-
2021-05-12
Registered in v-safe
-
2021-05-12
Survey response — day 21, dose 1MedDRA: Asthenia, Brain fog, Dizziness, Emotional distress, Fatigue, Gastrointestinal disorder, Headache, Insomnia, Malaise, Migraine, Nausea, Nervousness, Temperature regulation disorder, Tinnitus — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Headaches, migraines, nausea, dizziness, extreme fatigue+weakness, very low stamina, insomnia, tinnitus, brain fog, internal vibrations, impaired temperature regulation, GI issues, feeling really unwell + unable to function, 1st Pfizer dose:4/9/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-31
-
2021-07-19
Survey response — 3 months, dose 1MedDRA: Arthralgia, Dyspnoea, Fatigue, Headache, Lymph node pain, Muscular weakness, Myalgia, Pain in extremity, Tinnitus, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsening of weakness (especially legs), fatigue, pain in hands/fingers + feet/toes; muscle pain, sleep, joint pain, cognition + memory, tinnitus, sore lymph nodes, headaches, shortness of breath. Significant loss of function. 1st Pfizer shot on 4/9MedDRA releases: 2024-11 · check-in free text available
-
2021-07-19
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-26
- 2021-10-18
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 21, dose 1
Symptoms: Headaches, migraines, nausea, dizziness, extreme fatigue+weakness, very low stamina, insomnia, tinnitus, brain fog, internal vibrations, impaired temperature regulation, GI issues, feeling really unwell + unable to function, 1st Pfizer dose:4/9/21 cut off by CDC
Release 9 — 3 months, dose 1
Symptoms: Worsening of weakness (especially legs), fatigue, pain in hands/fingers + feet/toes; muscle pain, sleep, joint pain, cognition + memory, tinnitus, sore lymph nodes, headaches, shortness of breath. Significant loss of function. 1st Pfizer shot on 4/9 cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Brain fog | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Emotional distress | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrointestinal disorder | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Lymph node pain | · | · | ✓ |
| SD | Malaise | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Muscular weakness | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Nervousness | ✓ | ✓ | ✓ |
| SD | Pain in extremity | · | · | ✓ |
| SD | Temperature regulation disorder | ✓ | ✓ | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release